๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Crohn Disease
Clinical trial register · China

Crohn Disease Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 11 Hangzhou 10 Changzhou 6 Chongqing 5 Shanghai 4
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou11 Hangzhou10 Changzhou6 Chongqing5 Shanghai4
All 26 locations
Target enrolment
to

Crohn Disease trials in China

27 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Efficacy and Safety of CDED With Anti-TNF-ฮฑ Biologics in Crohn's Disease
NCT07344428Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
185
Guangzhou
2026-08-01
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843Crohn Disease
Janssen Research & Development, LLC
Phase 3
460
Beijing, Changzhou, Chongqing, Guangzhou, Hangzhou, Huai'an, Ningbo, Zhuzhou
2026-05-22
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
NCT07483073Colitis, Ulcerative, Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232Crohn Disease
Janssen Research & Development, LLC
Phase 3
530
Changzhou, Chongqing, Guangzhou, Nanjing, Wuhan
2026-04-21
Recruiting
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
NCT07310095Crohn Disease
Xian-Janssen Pharmaceutical Ltd.
Phase 4
78
Guangzhou, Hangzhou, Hefei, Shanghai
2025-12-30
Recruiting
Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease
NCT07364734Crohn Disease
Xiang Gao
Observational
1,400
Guangzhou
2025-11-01
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722Crohn Disease
Janssen Research & Development, LLC
Phase 2/3
1,092
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou
2025-10-03
Recruiting
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
NCT06939712Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou
2025-05-01
Recruiting
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
NCT06995170Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease, Polyamines
Xijing Hospital
Observational
146
Xi'an
2025-01-01
Not yet open
Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
NCT06739278Crohn Disease
Second Affiliated Hospital of Wenzhou Medical University
Observational
119
Wenzhou
2024-12-20
Recruiting
Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures
NCT06203782Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
102
Hangzhou
2024-12-16
Not yet open
Semi-elemental Versus Polymeric EEN in the Preoperative Optimization for Patients with CD
NCT06587178Crohn Disease, Nutrition Disorders, Surgery
Wei Zhou
Not applicable
304
Hangzhou
2024-10-01
Recruiting
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031Crohn Disease, Stricture; Bowel, Intestinal Stricture
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
239
Beijing, Chongqing, Guangzhou, Huai'an, Suzhou, Yangzhou, Hangzhou
2024-08-01
Recruiting
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
NCT06520397Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 4
214
Guangzhou
2024-07-15
By invitation
Endoscopic Balloon Dilatation Combined With PRP Injection in Colonic Stenosis in Crohn's Disease
NCT06165289Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
74
Guangzhou
2024-03-01
Active, closed
Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease
NCT06673134Crohn Disease
Tongji Hospital
Observational
100
Wuhan
2023-12-01
Recruiting
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
NCT05906576Crohn Disease
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 4
30
Beijing
2023-09-21
Not yet open
Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients
NCT05719766Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
200
Hangzhou, Huzhou, Shanghai, Shaoxing
2023-04-01
Recruiting
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
NCT05658081Crohn Disease, Recurrence
Jinling Hospital, China
Not applicable
236
Nanjing
2022-12-08
Recruiting
Combined Immunosuppression for Pediatric Crohn's Disease
NCT05043870Crohn Disease, Infliximab, Immunosuppression, Children, Only
Children's Hospital of Fudan University
Phase 4
128
Shanghai
2022-10-10
Recruiting
Specific Dietary Pattern for Crohn's Disease Patients Following Surgery
NCT05502965Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
35
Hangzhou
2022-09-17
Recruiting
Surgery vs Biologics for Treating Stricturing CD--a RCT
NCT05421455Crohn Disease
Zhu Weiming
Not applicable
138
Nanjing
2022-06-09
Recruiting
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
NCT05321745Crohn Disease
Biao Zou
Not applicable
40
Wuhan
2022-03-22
Active, closed
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
NCT05197049Crohn Disease
Janssen Research & Development, LLC
Phase 3
350
Bengbu, Changsha, Changzhou, Chengdu, Chongqing, Foshan, Fuzhou, Ganzhou
2022-01-19
Recruiting
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
NCT05321758Crohn Disease
Tongji Hospital
Not applicable
50
Wuhan
2020-03-22
Recruiting
Effect of Acupuncture on Mild to Moderate Active Crohn's Disease
NCT04187820Intestinal Disorder, Inflammatory Bowel Diseases, Crohn Disease
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
60
Shanghai
2019-06-01
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/crohn-disease

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies listing the condition Crohn Disease.

How many Crohn Disease trials are recruiting in China?

20 of the 27 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Crohn Disease), 27 studies
PhaseStudiesRecruitingShare
Not applicable12844.4%
Observational5318.5%
Phase 44414.8%
Phase 33211.1%
Phase 2227.4%
Phase 2/3113.7%

Most active sponsors

Lead sponsors with the most studies (Crohn Disease)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine54
Janssen Research & Development, LLC43
Sixth Affiliated Hospital, Sun Yat-sen University31
Eli Lilly and Company22
Tongji Hospital21
Biao Zou11
Children's Hospital of Fudan University11
Jinling Hospital, China11
Second Affiliated Hospital of Wenzhou Medical University10
Shanghai Institute of Acupuncture, Moxibustion and Meridian11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.